|
US6566065B1
(en)
|
1994-05-26 |
2003-05-20 |
Mcgill University |
Method of diagnosing schizophrenia by detecting a mutation in the (MTHFR) gene
|
|
GB9410620D0
(en)
|
1994-05-26 |
1994-07-13 |
Univ Mcgill |
cDNA for human mehylenetetrahydrofolate reductase
|
|
US6310052B1
(en)
|
1996-06-04 |
2001-10-30 |
Queen's University At Kingston |
Nitrate esters and their use for neurological conditions
|
|
US20050137191A1
(en)
*
|
1996-06-04 |
2005-06-23 |
Thatcher Gregory R. |
Nitrate esters and their use for mitigating cellular damage
|
|
US6274564B1
(en)
|
1996-09-18 |
2001-08-14 |
William J. Sarill |
Compositions of cobalamin and related corrinoids, and uses thereof
|
|
CH693255A5
(de)
*
|
1997-06-13 |
2003-05-15 |
Eprova Ag |
Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
|
|
DE69830069T3
(de)
|
1997-10-17 |
2012-02-09 |
Ark Therapeutics Ltd. |
Verwendung von hemmern des renin-angiotensin systems zur behandlung von hypoxie oder verringertem stoffwechsel
|
|
JPH11217330A
(ja)
*
|
1998-01-30 |
1999-08-10 |
Sumitomo Pharmaceut Co Ltd |
神経栄養因子分泌促進剤
|
|
EP1102578A4
(en)
*
|
1998-08-03 |
2005-05-18 |
Epigenesis Pharmaceuticals Inc |
NEW ANALGICAL, ANTIINFLAMMATORY AND WOUND HEALING ACTIVE SUBSTANCE
|
|
JP2002528507A
(ja)
*
|
1998-10-30 |
2002-09-03 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
神経疾患および病態心理学的疾患の治療および予防用の組成物
|
|
JP5220968B2
(ja)
*
|
1998-10-30 |
2013-06-26 |
ヨーロピアン ブランド パティスィペイションズ エス ア |
心臓血管疾患の治療および予防のための組成物
|
|
DE19913528A1
(de)
*
|
1998-12-21 |
2000-06-29 |
Sanol Arznei Schwarz Gmbh |
Neue Verwendung von Moexipril
|
|
BR0007397A
(pt)
*
|
1999-01-05 |
2001-10-30 |
Univ East Carolina |
Composição e formulações e seu uso como agentesnocicépticos, ansiolìticos e anabólicos
|
|
US7608640B2
(en)
|
1999-03-02 |
2009-10-27 |
Jallal Messadek |
Glycine betaine and its use
|
|
BE1012495A3
(fr)
*
|
1999-03-02 |
2000-11-07 |
Messadek Jallal |
La glycine-betaine pour son usage antithrombotique.
|
|
WO2000057879A1
(en)
*
|
1999-03-26 |
2000-10-05 |
Barry Reisberg |
Treatment of brain changes with myelin protective agents
|
|
CN1159984C
(zh)
*
|
1999-06-29 |
2004-08-04 |
新西兰奶制品研究所有限公司 |
基于奶的预防性饮食添加剂
|
|
WO2001013900A2
(en)
*
|
1999-08-24 |
2001-03-01 |
Medicure International Inc. |
Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
|
|
WO2001030352A1
(en)
*
|
1999-10-28 |
2001-05-03 |
Cary Pharmaceuticals Inc. |
High dose folic acid for the treatment of hyperhomocysteinemia
|
|
DE10004651A1
(de)
*
|
2000-02-03 |
2001-08-16 |
Jutta Dierkes |
Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
|
|
US7442689B2
(en)
|
2000-02-29 |
2008-10-28 |
Medicure International Inc. |
Cardioprotective phosphonates and malonates
|
|
WO2001072309A2
(en)
|
2000-03-28 |
2001-10-04 |
Medicure International Inc. |
Treatment of cerebrovascular disease
|
|
GB2361185A
(en)
*
|
2000-04-10 |
2001-10-17 |
Nicholas J Wald |
Pharmaceutical formulation for the prevention of cardiovascular disease
|
|
DE60119715T3
(de)
*
|
2000-04-10 |
2016-12-08 |
Nicholas John Wald |
Zusammensetzung zur prävention kardiovaskulärer erkrankungen
|
|
US7226916B1
(en)
*
|
2000-05-08 |
2007-06-05 |
N.V. Nutricia |
Preparation for the prevention and/or treatment of vascular disorders
|
|
DE10022510A1
(de)
*
|
2000-05-10 |
2001-11-15 |
Basf Ag |
Zusammensetzungen enthaltend Folsäure und reduziertes Folat
|
|
US7439052B2
(en)
|
2000-06-29 |
2008-10-21 |
Lipid Sciences |
Method of making modified immunodeficiency virus particles
|
|
US7407663B2
(en)
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified immunodeficiency virus particles
|
|
US20090017069A1
(en)
|
2000-06-29 |
2009-01-15 |
Lipid Sciences, Inc. |
SARS Vaccine Compositions and Methods of Making and Using Them
|
|
AUPQ846900A0
(en)
*
|
2000-06-29 |
2000-07-27 |
Aruba International Pty Ltd |
A vaccine
|
|
US7407662B2
(en)
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified viral particles with immunogenic properties and reduced lipid content
|
|
JP2004538262A
(ja)
*
|
2000-12-14 |
2004-12-24 |
タフツ ユニバーシティー |
関節炎状態を治療するための化合物および方法
|
|
US6537992B2
(en)
*
|
2001-01-05 |
2003-03-25 |
John D. Parker |
Regulation of organic nitrate tolerance
|
|
BR0101088A
(pt)
*
|
2001-03-19 |
2003-03-18 |
Biolab Sanus Farmaceutica Ltda |
Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.
|
|
CA2445512C
(en)
*
|
2001-04-25 |
2010-10-12 |
Cobalz Limited |
A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
|
|
US20060060520A1
(en)
|
2001-06-25 |
2006-03-23 |
Bomberger David C |
Systems and methods using a solvent for the removal of lipids from fluids
|
|
AU2002322284A1
(en)
|
2001-06-25 |
2003-01-08 |
Lipid Sciences, Inc. |
Systems and methods using multiple solvents for the removal of lipids from fluids
|
|
US20030127386A1
(en)
*
|
2001-06-25 |
2003-07-10 |
Bomberger David C. |
Hollow fiber contactor systems for removal of lipids from fluids
|
|
US6991727B2
(en)
*
|
2001-06-25 |
2006-01-31 |
Lipid Sciences, Inc. |
Hollow fiber contactor systems for removal of lipids from fluids
|
|
EP1438027A1
(en)
*
|
2001-10-25 |
2004-07-21 |
DepoMed, Inc. |
Methods of treatment using a gastric retained losartan dosage
|
|
JP2005500246A
(ja)
*
|
2001-12-03 |
2005-01-06 |
マギル ユニヴァーシティー |
メチレンテトラヒドロ葉酸還元酵素阻害剤およびそれらの使用
|
|
US20060160896A1
(en)
*
|
2002-02-04 |
2006-07-20 |
Jallal Messadek |
Therapeutic treatment
|
|
BE1015608A6
(fr)
*
|
2003-07-15 |
2005-06-07 |
Messadek Jallal |
Traitement des arterites.
|
|
CH696628A5
(de)
*
|
2002-02-26 |
2007-08-31 |
Eprova Ag |
Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
|
|
GB0212412D0
(en)
*
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
US20040162292A1
(en)
*
|
2002-12-03 |
2004-08-19 |
Evenstad Kenneth L. |
Multivitamin formulations for promoting healthy collagen, and methods of their use
|
|
WO2004091601A1
(fr)
*
|
2003-04-17 |
2004-10-28 |
Jallal Messadek |
Formulations orales flottantes pour la liberation controlee de la betaine
|
|
JP2007527387A
(ja)
|
2003-07-03 |
2007-09-27 |
リピッド サイエンシーズ，インコーポレイテッド |
脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
|
|
US7393826B2
(en)
|
2003-07-03 |
2008-07-01 |
Lipid Sciences, Inc. |
Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
|
|
US6951658B1
(en)
*
|
2003-07-08 |
2005-10-04 |
Pearson Research & Development Limited |
Emu-based compositions for mental well-being and method of use
|
|
US8173618B2
(en)
*
|
2003-07-25 |
2012-05-08 |
University Of Massachusetts |
Formulations for reducing neuronal degeneration
|
|
JPWO2005011736A1
(ja)
*
|
2003-07-30 |
2006-09-14 |
株式会社 東北テクノアーチ |
アルツハイマー病の予防および／または治療剤
|
|
US20050032741A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Balaji Venkataraman |
Vitamin Compositions
|
|
US20050032740A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Balaji Venkataraman |
Vitamin compositions for the treatment and prevention of vascular disease and dementia
|
|
JP4880591B2
(ja)
|
2004-06-04 |
2012-02-22 |
テバ ファーマシューティカル インダストリーズ リミティド |
イルベサルタンを含む医薬組成物
|
|
BE1016128A6
(fr)
*
|
2004-07-22 |
2006-03-07 |
Messadek Jallal |
Combinaisons therapeutiques
|
|
EP1645276A1
(en)
*
|
2004-10-08 |
2006-04-12 |
Wageningen Centre for Food Sciences |
Treatment of neurodegenerative disorders
|
|
WO2006050581A2
(en)
*
|
2004-11-10 |
2006-05-18 |
Jallal Messadek |
Betaine as agent against arthropod - or mosquito -borne diseases
|
|
EP2242489A1
(en)
|
2005-02-15 |
2010-10-27 |
Jallal Messadek |
Combination therapeutic compositions and method of use
|
|
BRPI0610249A2
(pt)
|
2005-04-27 |
2010-06-08 |
Jallal Messadek |
associação ou combinação farmacêutica, composição farmacêutica, processo de co-cristalização e o uso de insulina ou análogo de insulina
|
|
US20070010492A1
(en)
*
|
2005-07-11 |
2007-01-11 |
Generale Robert J |
Composition and method for reducing homocysteine caused by drugs containing methyl compounds
|
|
US20080193385A1
(en)
*
|
2007-02-08 |
2008-08-14 |
Todd Maibach |
Compositions and methods for treating neuropathy
|
|
US8178133B2
(en)
*
|
2007-03-22 |
2012-05-15 |
Magceutics, Inc. |
Magnesium compositions and uses thereof
|
|
GB0715502D0
(en)
*
|
2007-08-08 |
2007-09-19 |
Univ Manchester |
Methods
|
|
JP5376785B2
(ja)
*
|
2007-09-28 |
2013-12-25 |
小林製薬株式会社 |
医薬組成物
|
|
US8597640B2
(en)
*
|
2007-10-31 |
2013-12-03 |
University Of Massachusetts Lowell |
Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
|
|
WO2009065193A1
(en)
*
|
2007-11-21 |
2009-05-28 |
Jallal Messadek |
Treatment of aspirin resistance with betaine and/or betaine enriched molasses
|
|
JP5584411B2
(ja)
*
|
2007-12-27 |
2014-09-03 |
サントリーホールディングス株式会社 |
ホモシステイン低下用組成物
|
|
MX2013000319A
(es)
|
2010-07-01 |
2013-05-01 |
Isis Innovation |
Tratamiento de transtornos cognitivos.
|
|
US20150065448A1
(en)
*
|
2011-08-12 |
2015-03-05 |
The Florida State University Research Foundation Inc. |
Methods of treating amyloidoses with vitamin b12 and diagnostic test for detecting the presence of amyloid-beta peptides
|
|
US20150065449A1
(en)
|
2011-08-12 |
2015-03-05 |
Florida State University Research Foundation, Inc. |
Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
|
|
CN103386130A
(zh)
*
|
2013-06-27 |
2013-11-13 |
深圳奥萨医药有限公司 |
Ace抑制剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物及用途
|
|
US10661099B2
(en)
*
|
2015-06-16 |
2020-05-26 |
Eugene R. Moore |
Treatment of alzheimer's disease
|
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
|
US10201577B2
(en)
|
2017-02-14 |
2019-02-12 |
Keyview Labs, Inc. |
Compositions and methods for enhancing working and long-term memory support using new combination of ginkgo biloba and panax ginseng and associated components
|
|
EP3714039B1
(en)
|
2017-11-22 |
2025-03-12 |
HDL Therapeutics, Inc. |
Methods for priming fluid circuits of a plasma processing system
|
|
AU2018396009A1
(en)
|
2017-12-28 |
2020-07-16 |
Hdl Therapeutics, Inc. |
Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
|
|
US11318144B2
(en)
|
2019-04-12 |
2022-05-03 |
LA PharmaTech Inc. |
Compositions and methods for treating Alzheimer's disease and Parkinson's disease
|
|
US11690849B2
(en)
|
2019-04-12 |
2023-07-04 |
LA PharmaTech Inc. |
Method of treating dementia
|
|
US11744833B2
(en)
|
2019-04-12 |
2023-09-05 |
LA PharmaTech Inc. |
Pharmaceutical compositions and methods for treatment of insomnia
|
|
US11547688B2
(en)
*
|
2019-08-22 |
2023-01-10 |
Nodari Rizun |
Amino acid compositions and methods of manufacturing the compositions
|
|
US11351179B1
(en)
|
2021-08-05 |
2022-06-07 |
LA PharmaTech Inc. |
Pharmaceutical compositions and methods for treatment of psychiatric disorders
|